news
Lundbeck Research USA, Inc. & BioFocus sign compound management agreement
26 January 2011 | By BioFocus
BioFocus has signed a 3 year compound management services agreement with Lundbeck Research USA...
List view / Grid view
Lundbeck Research USA
article
Biomarkers in CNS drug discovery and development – focus on molecular blood markers
29 May 2009 | By
In established economies, mental disorders account for a larger burden of disease than all cancers combined. Yet reliable, measurable, markers of such diseases (biomarkers) are not uniformly known and without them, prediction that a new drug candidate makes contact with its target is poor. This is unfortunate because the attrition…
article
Designing a program for early CNS development
28 November 2006 | By Irina Antonijevic, Douglas Craig and Christophe Gerald, Lundbeck Research USA, Inc.
Only a few innovations have been made in recent decades with regard to psychiatric, and particularly antidepressant, drugs (Insel et al., 2006) (Figure 1). This conundrum reflects, at least partly, the lack of understanding of the disease biology. This poses a challenge not only to inventive drug development, but also…
